Previous Article | Next Article 
Journal of Clinical Microbiology, December 1999, p. 4124-4126, Vol. 37, No. 12
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Leuconostoc pseudomesenteroides as a
Cause of Nosocomial Urinary Tract Infections
Elisabete A.
Cappelli,1
Rosana R.
Barros,2
Thereza Cristina F.
Camello,3
Lúcia M.
Teixeira,2 and
Vânia Lúcia C.
Merquior1,*
Faculdade de Ciências
Médicas1 and Hospital
Universitário Pedro Ernesto,3 Universidade
do Estado do Rio de Janeiro, Rio de Janeiro 20551, and
Instituto de Microbiologia Prof. Paulo de Goes,
Universidade Federal do Rio de Janeiro, Rio de Janeiro
21941,2 Brazil
Received 9 December 1998/Returned for modification 1 June
1999/Accepted 9 August 1999
 |
ABSTRACT |
The phenotypic and genotypic characterization of five clinical
isolates of Leuconostoc pseudomesenteroides associated with nosocomially acquired urinary tract infections is described. All the
strains were susceptible to chloramphenicol, clindamycin, erythromycin,
gentamicin, and tetracycline; all were resistant to nalidixic acid,
norfloxacin, and vancomycin; and all were intermediately affected by
ampicillin and penicillin. Analysis of chromosomal DNA by pulsed-field
gel electrophoresis after treatment with SmaI indicated a
clonal relationship of the isolates. The results provide evidence for
the possibility of nosocomial transmission of this unusual
opportunistic, vancomycin-resistant pathogen.
 |
TEXT |
The genus Leuconostoc is
composed by catalase-negative gram-positive microorganisms with
irregular coccoid morphology. These organisms may be misidentified as
Lactobacillus, Streptococcus (particularly the
viridans group), Pediococcus, or even
Enterococcus, as all share several biochemical properties
(3, 20). Unlike most other gram-positive bacteria, these
microorganisms have an important physiological marker related to their
intrinsic resistance to vancomycin (6, 18). Before 1985, Leuconostoc species were usually considered nonpathogenic
and, therefore, of little or no importance in clinical microbiology
(3, 19). Since then, increasing numbers of infections due to
Leuconostoc have been reported (1, 2, 8-12, 23).
Despite remaining uncommon, these pathogens are gaining importance as
opportunistic agents of human infections associated with high mortality
rates, mainly bacteremia (14, 15, 18). Infections due to
Leuconostoc occur more frequently in patients being treated
for underlying diseases with vancomycin therapy (7, 13),
although Leuconostoc infections have also been
documented in otherwise healthy patients (4). The
present study describes the phenotypic and genotypic characterization of a cluster of five Leuconostoc pseudomesenteroides strains
recovered from hospitalized patients with symptomatic urinary tract
infections, providing evidence for the possible nosocomial transmission
of this opportunistic vancomycin-resistant bacterium.
Five clinical isolates of catalase-negative, vancomycin-resistant,
gram-positive cocci recovered from urine specimens obtained from five
inpatients admitted to a University Hospital in Rio de Janeiro, Brazil,
were studied. The strains were isolated within a period of 1 week (in
April 1997) from patients in two units (nephrology and urology) located
on the same hospital floor. Clinical manifestations of the infections
included dysuria and/or fever, and the microorganisms grew in pure
cultures. All five patients had been admitted to the hospital due to
other medical conditions, and only one of the patients had a urinary
catheter at the time the culture-positive urine was collected. The most
common risk factors associated with infection acquisition are described
in Table 1.
Identification of the strains to the genus level was performed as
described elsewhere (6) by using tests for detecting the
following physiological characteristics: presence of catalase, pyrrolidonyl arylamidase and leucine aminopeptidase activities, hydrolysis of esculin in the presence of bile, growth in the presence of 6.5% NaCl, vancomycin susceptibility, and production of gas in
lactobacilli De Mann, Rogosa, and Sharp (MRS; Difco Laboratories, Detroit, Mich.) broth. Additional physiological tests, including production of acids from arabinose, lactose, maltose, melibiose, salicin, sucrose, threalose, and xylose, were used for the
characterization of the isolates to the species level. All five
clinical isolates had similar physiological characteristics. They were
negative for catalase, pyrrolidonyl arylamidase, and leucine
aminopeptidase activities and did not grow in broth containing 6.5%
NaCl. They all were resistant to vancomycin, were esculin-positive in
bile, produced gas in MRS broth, and produced acid from arabinose,
lactose, maltose, melibiose, salicin, sucrose, threalose, and xylose.
On the basis of these results, the most likely identity of the isolates was L. pseudomesenteroides. The isolation of L. pseudomesenteroides from human clinical specimens is rare, and, to
the best of our knowledge, there are no specific reports of its
association with urinary tract infections. The majority of
Leuconostoc strains associated with human infections have
been identified as Leuconostoc mesenteroides, followed by
Leuconostoc lactis and Leuconostoc citreum
(5, 6). On the other hand, the discrimination between species of Leuconostoc is often problematic, and the
description of the role of each individual species as infectious agent
has possibly been hindered by the difficulty of precise identification. Differentiation of L. pseudomesenteroides and the most
frequent species, L. mesenteroides, is mainly based
on the results of growth in 6.5% NaCl, a test which is sometimes
difficult to interpret and to reproduce (5, 6).
To confirm the identification of the isolates, analysis of
whole-cell protein profiles using one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis was performed as
described by Merquior et al. (16). This method has been
considered to be a reliable and reproducible tool for the
differentiation and identification of several species of
catalase-negative, gram-positive cocci, including
Leuconostoc spp. (5, 21, 22). Protein profiles
were compared and clustered by the unweighted pair group method
with averages by using the Molecular Analyst Fingerprint Plus software
of the Image Analysis System (Bio-Rad Laboratories, Richmond,
Calif.). The clinical isolates had virtually indistinguishable protein profiles (Fig. 1) and had higher
similarity (average similarity, 89%) with the profile of the L. pseudomesenteroides type strain (SS 1292, ATCC 12291) than with
that of the L. mesenteroides type strain (SS 1238, ATCC
8293). These findings confirmed the identification based on
conventional physiological tests and indicate that analysis of
whole-cell protein profiles can be recommended as an additional tool
for the precise identification of L. pseudomesenteroides.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis profiles of whole-cell protein extracts of
Leuconostoc strains. Lane 1, molecular mass markers (in
kilodaltons); lane 2, L. mesenteroides ATCC 8293; lane 3, L. pseudomesenteroides ATCC 12291; lanes 4-8, clinical
isolates of L. pseudomesenteroides. (B) Dendrogram
resulting from computer-assisted analysis of the protein profiles shown
in panel A. The scale represents the average percentage of
similarity.
|
|
MICs were determined by the microdilution method according to the
recommendations of the National Committee for Clinical Laboratory Standards for Streptococcus spp. other than
Streptococcus pneumoniae (17), since no criteria
are specified for Leuconostoc strains. Results indicated
that the clinical isolates were susceptible to chloramphenicol
(MIC = 8 µg/ml), clindamycin (0.015 µg/ml), erythromycin (0.1 µg/ml), gentamicin (0.12 µg/ml), and tetracycline (4 µg/ml) and
were resistant to nalidixic acid (MIC = 128 µg/ml), norfloxacin
(32 µg/ml), and vancomycin (512 µg/ml). Intermediate results were
obtained for ampicillin (MIC = 2 µg/ml) and penicillin (1 µg/ml). No strain-to-strain variation in the MICs was observed.
The genotypic relationship of the strains was investigated by analysis
of SmaI-digested chromosomal DNA by pulsed-field gel electrophoresis (PFGE) based on the procedure recommended by Teixeira et al. (21). The following parameters for electrophoresis
were used: voltage gradient, 6 V/cm; running time, 22 h;
temperature, 11°C; pulse time, ramping from 2 to 25 s; and
included angle, 120°. The PFGE patterns of all the isolates were
found to be identical, and they were distinct from the pattern obtained
for the L. pseudomesenteroides type strain (Fig.
2). These data suggested that the
isolates may have originated from a common source.

View larger version (89K):
[in this window]
[in a new window]
|
FIG. 2.
PFGE patterns of chromosomal DNA of
Leuconostoc strains after digestion with SmaI.
Lane 1, molecular size markers (in kilobases); lane 2, L. mesenteroides ATCC 8293; lane 3, L. pseudomesenteroides
ATCC 12291; lanes 4-8, clinical isolates of L. pseudomesenteroides.
|
|
In conclusion, this report presents the phenotypic and genotypic
characterization of a cluster of five L. pseudomesenteroides strains associated with nosocomially
acquired urinary tract infections. Taken together, the isolation,
within a short period of time, of such a rare opportunistic bacterial
species, in pure cultures and in significant numbers, from the urine of
symptomatic patients in two related hospital units, in association with
the results of genotypic characterization of the isolates, provided
evidence of the outbreak potential and the risk of possible nosocomial transmission of this vancomycin-resistant bacterial species. With the
increased use of vancomycin, infections due to vancomycin-resistant microorganisms, such as Leuconostoc, may be more frequently
encountered, especially in debilitated individuals. The observation of
the outbreak described in this paper highlights the need for clinical laboratories to be aware of the potential clinical significance of
these bacteria and to be prepared to promptly and accurately identify
them. The incorporation of precise procedures into the catalase-negative, gram-positive coccus identification schemes and the
application of molecular tools will allow proper detection and
characterization of unusual pathogens such as Leuconostoc species, thereby improving our knowledge of the epidemiological aspects
of human infections caused by these microorganisms and their routes of transmission.
 |
ACKNOWLEDGMENTS |
This investigation was supported by Conselho Nacional de
Desenvolvimento Científico e Tecnológico (CNPq),
Coordenação de Aperfeiçoamento de Pessoal de
Nível Superior (CAPES), Financiadora de Estudos e Projetos
(FINEP), Fundação de Amparo à Pesquisa do Estado do
Rio de Janeiro (FAPERJ), and Ministério da Ciência e
Tecnologia (MCT/PRONEX).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Disciplina de
Microbiologia e Imunologia, Faculdade de Ciências Médicas,
Universidade do Estado do Rio de Janeiro, Av. 28 de Setembro, 87-fds /
3° andar Vila Isabel, 20551 Rio de Janeiro, RJ, Brazil. Phone: 55 21 587 6380. Fax: 55 21 587 6476. E-mail: merquior{at}uerj.br.
 |
REFERENCES |
| 1.
|
Barreau, C., and G. Wagener.
1990.
Characterization of Leuconostoc lactis strains from human sources.
J. Clin. Microbiol.
28:1728-1733[Abstract/Free Full Text].
|
| 2.
|
Barry, H.,
M. T. Clancy,
A. Brady, and N. O'Higgins.
1993.
Isolation of a Leuconostoc species from a retroareolar breast abscess.
J. Infect.
27:208-210[Medline].
|
| 3.
|
Buu-Hoi, A.,
C. Branger, and J. F. Acar.
1985.
Vancomycin-resistant streptococci or Leuconostoc sp.
Antimicrob. Agents Chemother.
28:458-460[Abstract/Free Full Text].
|
| 4.
|
Coovadia, Y. M.,
Z. Solwa, and J. Van Den Ende.
1987.
Meningitis caused by vancomycin-resistant Leuconostoc sp.
J. Clin. Microbiol.
25:1784-1785[Abstract/Free Full Text].
|
| 5.
|
Elliot, J. A., and R. R. Facklam.
1993.
Identification of Leuconostoc spp. by analysis of soluble whole-cell protein patterns.
J. Clin. Microbiol.
31:1030-1033[Abstract/Free Full Text].
|
| 6.
|
Facklam, R., and J. A. Elliott.
1995.
Identification, classification, and clinical relevance of catalase-negative, gram-positive cocci, excluding streptococci and enterococci.
Clin. Microbiol. Rev.
8:479-495[Abstract].
|
| 7.
|
Ferrer, S.,
G. Miguel,
P. Domingo,
R. Pericas, and G. Prats.
1995.
Pulmonary infection due to Leuconostoc species in a patient with AIDS.
Clin. Infect. Dis.
21:225-226[Medline].
|
| 8.
|
Friedland, I. R.,
M. Snipelisky, and M. Khoosal.
1990.
Meningitis in a neonate caused by Leuconostoc sp.
J. Clin. Microbiol.
28:2125-2126[Abstract/Free Full Text].
|
| 9.
|
Giacometti, A.,
R. Ranaldi,
F. M. Siquini, and G. Scalise.
1993.
Leuconostoc citreum isolated from lung in AIDS patient.
Lancet
342:622[Medline].
|
| 10.
|
Golledge, C. L.
1991.
Infection due to Leuconostoc species.
Rev. Infect. Dis.
13:184-185[Medline].
|
| 11.
|
Green, M.,
R. M. Wadowsky, and K. Barbadora.
1990.
Recovery of vancomycin-resistant gram-positive cocci from children.
J. Clin. Microbiol.
28:484-488[Abstract/Free Full Text].
|
| 12.
|
Handwerger, S.,
H. Horowitz,
K. Coburn,
A. Kolokathis, and G. P. Wormser.
1990.
Infection due to Leuconostoc species: six cases and review.
Rev. Infect. Dis.
12:602-610[Medline].
|
| 13.
|
Horowitz, H. W.,
S. Handwerger,
K. G. van Horn, and G. P. Wormser.
1987.
Leuconostoc, an emerging vancomycin-resistant pathogen.
Lancet
ii:1329-1330.
|
| 14.
|
Jiménez-Mejías, M. E.,
B. Becerril,
T. Gómez-Cía,
M. Del Nozal, and J. Palomino-Nicás.
1997.
Bacteremia caused by Leuconostoc cremoris in a patient with severe burn injuries.
Eur. J. Clin. Microbiol. Infect. Dis.
16:533-535[Medline].
|
| 15.
|
Ling, M. L.
1992.
Leuconostoc bacteraemia.
Singapore Med. J.
33:241-243[Medline].
|
| 16.
|
Merquior, V. L. C.,
J. M. Peralta,
R. R. Facklam, and L. M. Teixeira.
1994.
Analysis of electrophoretic whole-cell protein profiles as a toll for characterization of Enterococcus species.
Curr. Microbiol.
28:149-153.
|
| 17.
|
National Committee for Clinical Laboratory Standards.
1997.
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Document M7-A4.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 18.
|
Quirós, J. C. L. B.,
P. Munõz,
E. Cercenado,
T. H. Sampelayo,
S. Moreno, and E. Bouza.
1991.
Leuconostoc species as a cause of bacteremia: two case reports and a literature review.
Eur. J. Clin. Microbiol. Infect. Dis.
10:505-509[Medline].
|
| 19.
|
Rubin, L. G.,
E. Vellozzi,
J. Shapiro, and H. D. Isenberg.
1988.
Infection with vancomycin-resistant "streptococci" due to Leuconostoc species.
J. Infect. Dis.
157:216[Medline].
|
| 20.
|
Ruoff, K. L.,
D. R. Kuritzkes,
J. S. Wolfson, and M. J. Ferraro.
1988.
Vancomycin-resistant gram-positive bacteria isolated from human sources.
J. Clin. Microbiol.
26:2064-2068[Abstract/Free Full Text].
|
| 21.
|
Teixeira, L. M.,
M. G. S. Carvalho,
V. L. C. Merquior,
A. G. Steigerwalt,
D. J. Brenner, and R. R. Facklam.
1997.
Phenotypic and genotypic characterization of Vagococcus fluvialis, including strains isolated from human sources.
J. Clin. Microbiol.
35:2778-2781[Abstract].
|
| 22.
|
Villani, F.,
G. Moschetti,
G. Blaiotta, and S. Coppola.
1997.
Characterization of strains of Leuconostoc mesenteroides by analysis of soluble whole-cell protein pattern, DNA fingerprint and restriction of ribosomal DNA.
J. Appl. Microbiol.
82:578-588[Medline].
|
| 23.
|
Wenocur, H. S.,
M. A. Smith,
E. M. Vellozzi,
J. Shapiro, and H. D. Isenberg.
1988.
Odontogenic infection secondary to Leuconostoc species.
J. Clin. Microbiol.
26:1893-1894[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, December 1999, p. 4124-4126, Vol. 37, No. 12
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Albanese, A., Spanu, T., Sali, M., Novegno, F., D'Inzeo, T., Santangelo, R., Mangiola, A., Anile, C., Fadda, G.
(2006). Molecular Identification of Leuconostoc mesenteroides as a Cause of Brain Abscess in an Immunocompromised Patient.. J. Clin. Microbiol.
44: 3044-3045
[Abstract]
[Full Text]